4-Methylmorpholine → HCID 50923462, compound
Reaction equation
[NH2:1][C:2]1[N:7]=[CH:6][C:5]([C:8]2[CH:9]=[N:10][N:11]([CH2:13][C:14]([OH:16])=O)[CH:12]=2)=[CH:4][C:3]=1[C:17]1[NH:21][C:20]2[CH:22]=[C:23]([O:26][CH3:27])[CH:24]=[CH:25][C:19]=2[N:18]=1.[F:28][C:29]1[CH:30]=[C:31]([CH:34]=[CH:35][C:36]=1[F:37])[CH2:32][NH2:33].C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1>CN(C=O)C.O.C(OCC)(=O)C.C(Cl)CCl>[NH2:1][C:2]1[N:7]=[CH:6][C:5]([C:8]2[CH:9]=[N:10][N:11]([CH2:13][C:14]([NH:33][CH2:32][C:31]3[CH:34]=[CH:35][C:36]([F:37])=[C:29]([F:28])[CH:30]=3)=[O:16])[CH:12]=2)=[CH:4][C:3]=1[C:17]1[NH:21][C:20]2[CH:22]=[C:23]([O:26][CH3:27])[CH:24]=[CH:25][C:19]=2[N:18]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
4a.2 146 mg of {4-[6-amino-5-(6-methoxy-1H-benzimidazol-2-yl)pyridin-3-yl]pyrazol-1-yl}acetic acid (0.120 mmol) are dissolved in 1.5 ml of DMF. 17.5 mg (0.120 mmol) of 3,4-difluorobenzylamine, 16.2 mg (0.120 mmol) of HOBt, 23 mg (0120 mmol) of EDC and 26.4 μl (0.240 mmol) of N-methylmorpholine are added. The reaction mixture is stirred at room temperature for 14 h, and water/ethyl acetate is subsequently added. The aqueous phase is extracted 2× with ethyl acetate. The combined organic phases are washed with water, dried using sodium sulfate, filtered and evaporated to dryness. The residue is purified by means of preparative RP-HPLC, giving 2-{4-[6-amino-5-(6-methoxy-1H-benzimidazol-2-yl)pyridin-3-yl]pyrazol-1-yl}-N-(3,4-difluorobenzyl)acetamide; HPLC-MS [M+H]+ 490.2;
Workup
- extractionThe aqueous phase is extracted 2× with ethyl acetate
- washThe combined organic phases are washed with water
- customdried
- filtrationfiltered
- customevaporated to dryness
- customThe residue is purified by means of preparative RP-HPLC
Sources & evidence
- ORD record
- ord-531eab012d124fa88d7ea7b7adc7b14c
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08648201B2
Reaction notes
Loading…